Gainers
- Obseva SA OBSV climbed 34 percent to $19.50 The clinical-stage biopharma company that focuses on addressing conditions related to reproductive health and pregnancy said its phase 2b clinical trial of its linzagolix therapy achieved primary and secondary endpoints.
- Gevo, Inc. GEVO shares jumped 31.7 percent to $4.624 after the company disclosed that the EPA has approved registration of isobutanol in 16% blends in gasoline.
- PTC Therapeutics, Inc. PTCT shares jumped 27.5 percent to $47.88 in pre-market trading. The biopharmal company that develops treatments for rare disorders announced updated interim clinical data from a clinical study of its risdiplam therapy in babies with Type 1 Spinal Muscular Atrophy. William Blair upgraded PTC Therapeutics from Market Perform to Outperform.
- Xspand Products Lab, Inc. XSPL surged 26.1 percent to $9.5298. Xspand Products Lab reported development of a new line of interactive light-up consumer products.
- China Biologic Products Holdings, Inc. CBPO shares surged 23.9 percent to $101.64 following 13D filing indicating non-binding offer for $110 per share.
- Rent-A-Center Inc RCII gained 22.4 percent to $14.73 on news that the board unanimously approved a sale to Vintage Capital for about $1.365 billion including debt.
- Verastem, Inc. VSTM rose 18.9 percent to $7.761 after the company’s duvelisib showed robust clinical activity in CLL.
- Energy XXI Gulf Coast, Inc. EGC jumped 18.7 percent to $8.89 after acquisition by Cox Oil for $9.10 per share in cash.
- Surface Oncology, Inc. SURF rose 17 percent to $16.94.
- Francesca's Holdings Corporation FRAN gained 14.9 percent to $7.02. B. Riley FBR upgraded Francesca's from Neutral to Buy.
- Nano Dimension Ltd. NNDM rose 14.6 percent to $2.67.
- Monaker Group, Inc. MKGI climbed 14.3 percent to $3.20.
- Puxin Limited NEW rose 14.2 percent to $23.99 after climbing 23.53 percent on Friday.
- Cocrystal Pharma, Inc. COCP gained 14.1 percent to $3.80.
- Quotient Limited QTNT climbed 13.7 percent to $8.1175 in pre-market trading. Quotient reported concordance data from the MosaiQ European field trial.
- Stein Mart, Inc. SMRT shares rose 12.7 percent to $2.85
- Hebron Technology Co., Ltd. HEBT gained 11.9 percent to $2.305.
- Teekay Tankers Ltd. TNK rose 10.9 percent to $1.12. Teekay Tankers Shareholders expanded the number of authorized shares from 285,000 to 485,000. Wells Fargo upgraded Teekay from Market Perform to Outperform.
- Penn Virginia Corporation PVAC rose 9 percent to $83.97. Penn Virginia will replace Analogic in the S&P SmallCap 600 on Friday, June 22.
- Vince Holding Corp. VNCE gained 8.2 percent to $16.12.
- TapImmune, Inc. TPIV rose 8.1 percent to $11.35.
- Navios Maritime Partners L.P. NMM shares rose 7.3 percent to $1.91. Navios Maritime reported the sale of one containership and options to sell four additional containerships.
- Frontline Ltd. FRO shares rose 6.4 percent to $5.83. Wells Fargo upgraded Frontline from Market Perform to Outperform.
- Solid Biosciences Inc SLDB gained 6 percent to $28.09 in reaction to a favorable development with the FDA. The company that focuses on treatments for Duchenne muscular dystrophy said the FDA removed a clinical hold on its investigational therapy SGT-001 after addressing the agency's questions.
- Evofem Biosciences, Inc. EVFM rose 5.8 percent to $3.47. Oppenheimer initiated coverage on Evofem Biosciences with an Outperform rating.
- Quad/Graphics, Inc. QUAD gained 5.8 percent to $21.64. Buckingham initiated coverage on Quad/Graphics with a Buy rating.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Catalyst Biosciences, Inc. CBIO dipped 56.7 percent to $10.93 after the company issued an update on CB 2679d/ISU304 Factor IX clinical program in hemophilia B.
- Ambow Education Holding Ltd. AMBO fell 21 percent to $5.81 after climbing 79.27 percent on Friday.
- Apollo Medical Holdings, Inc. AMEH shares declined 19.3 percent to $20.87 after surging 59.53 percent on Friday.
- NF Energy Saving Corporation NFEC shares fell 18.9 percent to $3.05.
- Hexindai Inc. HX shares declined 18.9 percent to $9.46.
- Cytokinetics, Incorporated CYTK declined 16.2 percent to $8.30 after the company reported that data from Phase 2 clinical study of reldesemtiv in patients with spinal muscular atrophy were presented at the 2018 Annual Cure SMA Conference.
- InVivo Therapeutics Holdings Corp. NVIV slipped 15.8 percent to $4.885
- ZIOPHARM Oncology, Inc. ZIOP dropped 13.7 percent to $3.71 after the company disclosed that the FDA has placed a clinical hold on a Phase 1 trial to evaluate CD19-specific CAR-T therapies.
- Baytex Energy Corp. BTE shares tumbled 12.2 percent to $3.3900 as the company announced plans to buy Raging River.
- Melinta Therapeutics, Inc. MLNT dropped 10.3 percent to $8.117.
- MarineMax, Inc. HZO fell 9.6 percent to $21.65. B. Riley FBR downgraded MarineMax from Buy to Neutral.
- Grupo Supervielle S.A. SUPV shares dropped 9.1 percent to $13.23.
- iPic Entertainment Inc. IPIC shares fell 8.4 percent to $8.935
- Superior Drilling Products, Inc. SDPI shares declined 8 percent to $1.89.
- BBVA Banco Francés S.A. BFR fell 7.1 percent to $13.67.
- Intel Corporation INTC dropped 4.2 percent to $52.83. Northland Securities downgraded Intel from Market Perform to Underperform.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasInformation TechnologyIT Consulting & Other ServicesLosersTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in